Critical Care

official impact factor 4.60

Open Access Highly Access Research

Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

Bernd Muellejans*, Thomas Matthey, Joachim Scholpp and Markus Schill

Critical Care 2006, 10:R91 doi:10.1186/cc4939

No comments have yet been made on this article.

Post a comment